Updated:
Furiex Pharmaceuticals, Inc.
Furiex Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001484478, and its reported...
Overview
Furiex Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001484478, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2014-03-17, it reported annual revenue of USD 70,999,000; net income of USD -29,673,000; total assets of USD 88,442,000 for the fiscal period ended 2013-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Furiex Pharmaceuticals, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Morrisville, NC, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001484478
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2013USD | $71.0M | -$29.7M | $88.4M | $29.2M | -$23.1M | |
| FY2012USD | $40.5M | -$42.9M | $94.8M | $25.7M | -$40.6M | |
| FY2011USD | $4.5M | -$49.0M | $95.1M | $33.6M | -$49.0M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| SC 13D | — | SC 13D | |
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| SC 13D | — | SCHEDULE 13D | |
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| SC 13G | — | MS INITIAL | |
| 8-K | FORM 8-K | ||
| SC 13D | — | SCHEDULE 13D | |
| 8-K | 8-K | ||
| DEF 14A | FORM DEF 14A | ||
| 10-K | FORM 10-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Furiex Pharmaceuticals, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.